BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S SYNDROME

Patent Number: US-20240174761-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: US

Status: Pending

Inventors:

ELLIOTT BRIAN ELLIOTT BRIAN VALENTIN REBECCA X M S VALENTIN REBECCA X M S HOEHN DANIELA HOEHN DANIELA RIOS MARCIA RIOS MARCIA

Applicants:

  1. Genmab (Denmark)
    2. [NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]
  2. GENMAB AS
    3. [NORA names: Genmab; Private Research]
  3. Genmab AS
    4. [NORA names: Genmab; Private Research]

Abstract

Provided are methods of clinical treatment of Richter's syndrome in human subjects using a bispecific antibody which binds to CD3 and CD20.

Patent Family Records (2)

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S SYNDROME  

GENMAB AS, Genmab (Denmark) ELLIOTT BRIAN, VALENTIN REBECCA X M S, HOEHN DANIELA, (...more)

2024, WO-2024094822-A1

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S SYNDROME

GENMAB AS, Genmab (Denmark) ELLIOTT BRIAN, VALENTIN REBECCA X M S, HOEHN DANIELA, (...more)

2024, US-20240174761-A1

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link